Emicizumab-kxwh Subcutaneous and Nia-Chrom
Determining the interaction of Emicizumab-kxwh Subcutaneous and Nia-Chrom and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: chromium picolinate
Brand name: Cr-GTF, CRM, Chromium GTF
Synonyms: Chromium picolinate, Chromium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Niacin
- Emicizumab-kxwh Subcutaneous-Niacin and Lovastatin
- Emicizumab-kxwh Subcutaneous-Niacin and Simvastatin
- Emicizumab-kxwh Subcutaneous-Niacin Capsules and Tablets
- Emicizumab-kxwh Subcutaneous-Niacin Controlled-Release Capsules and Controlled-Release Tablets
- Emicizumab-kxwh Subcutaneous-Niacin SR
- Nia-Chrom-Emla
- Nia-Chrom-Emla Topical
- Nia-Chrom-Emo-Cort Scalp Solution Topical application
- Nia-Chrom-Emo-Cort Topical application
- Nia-Chrom-Emoquette
- Nia-Chrom-Empagliflozin